Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF)

Project Title Spironolactone Use in Patients with Reduced Ejection Fraction Heart Failure (HFrEF) or Preserved Ejection Fraction Heart Failure (HFpEF)
Date Posted
Wednesday, August 26, 2020
Project ID
cder_mpl1p_wp040
Status
Complete
Deliverables
Related Links
Description

In this report we examined the number of individuals with reduced ejection fraction heart failure (HFrEF) or preserved ejection fraction heart failure (HFpEF) in the Sentinel Distributed Database (SDD) and described the utilization of spironolactone among these individuals.

The study period included data from July 1, 2010 to September 30, 2018. We distributed the request to 16 Data Partners on February 13, 2020.

Medical Product
spironolactone
Population / Cohort
All individuals
Time Period
July 1, 2010 - September 30, 2018
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top